Article info

Download PDFPDF
Original article
Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation

Authors

  1. Correspondence to Dr Ad A van Bodegraven, Department of Gastroenterology, VU University Medical Center, PO Box 7057, Amsterdam 1007 MB, The Netherlands; v.bodegraven{at}vumc.nl
View Full Text

Citation

van Bodegraven AA, Bravenboer N, Witte BI on behalf of the Dutch Initiative on Crohn and Colitis (ICC), et al
Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation

Publication history

  • Received June 27, 2013
  • Revised September 30, 2013
  • Accepted October 1, 2013
  • First published October 21, 2013.
Online issue publication 
August 03, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.